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Background: The present study evaluated the predictive value of renal resistive index (RI) for renal function and
blood pressure (BP) outcome in hypertensive patients with unilateral atherosclerotic renal artery stenosis submitted
to successful revascularization.
Methods: In 158 hypertensive patients with atherosclerotic renal artery stenosis RI was acquired. Twelve months
after revascularization, they were classified on the basis of renal function and BP outcome as benefit (BP < 140/
90 mmHg or diastolic BP reduction > 15 mmHg with the same of reduced drugs; decrease in glomerular filtration
rate > 20%), or failure.
Results: Regarding renal function outcome, RI in the stenotic and in the contralateral kidney were significantly
higher in patients with failure (n = 20) than in those with benefit (0.72 ± 0.11 vs 0.61 ± 0.11 and 0.76 ± 0.08 vs 0.66 ±
0.09, p < 0.05). Among different cutpoints generated, RI in the contralateral kidney >0.73 provided the largest area
under the curve (0.77), and the highest sensitivity (80%) and specificity (72%). In the multivariate logistic regression
analysis, RI in the contralateral kidney >0.73 was an independent predictor of a failure in renal function outcome.
Regarding BP outcome, patients with no benefit from revascularization (n = 60) had similar RI in the stenotic and
contralateral kidney (p = ns), but presented higher pulse pressure, albuminuria and hypertension duration in
comparison to patients with improved BP control.
Conclusions: RI in the contralateral kidney is an independent predictor of renal function outcome after successful
revascularization in hypertensive patients with unilateral atherosclerotic renal artery stenosis, whereas it is not able
to predict blood pressure outcome.
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In the last decades the prevalence of atherosclerotic
renal artery stenosis (ARAS), possible cause of secondary
hypertension and ischemic nephropathy, has progres-
sively increased in Western countries, due both to the
aging of the population and to improved technical cap-
ability of detecting it [1]. The debate of treating ARAS
by using medical therapy or interventional procedures,
such as angioplasty with or without stenting, is still open
[2-7]. Considering the large variability among patients in
terms of risk factors and global risk, as well as the stage
of renal damage, the revascularization procedure in an
unselected population might be associated with variable
outcome. Therefore, at the moment the real challenge is
the possibility to identify reliable parameters that can be
used to detect patients that could benefit from such
procedure.
The renal resistive index (RI), measured by duplex
ultrasound, has been suggested to be a useful prognostic
tool, that enables to identify patients who will not bene-
fit from revascularization in terms of renal function or
blood pressure (BP) improvement [8-11]. In particular
Radermacher and coauthors showed that a cut-off of
0.80 presented an excellent sensitivity (96%), despite a
low specificity (53%) [9]. After the brilliant report of this
single-center study, other authors tested the predictive
role of RI for renal function and BP outcome, with con-
flicting results [12]. Indeed, some studies confirmed a
predictive role of increased RI for either renal function
[13,14] and BP outcome [13,15-17], while in other stud-
ies the association of increased RI and renal [8,15] or BP
outcome [18] was inconsistent. Furthermore, these studies
are heterogeneous regarding chosen cut-off, definition of
outcome, clinical characteristics of the studied population,
duration of follow-up, type of intervention, and sample
size, making difficult to draw clear conclusions.
Therefore, the aim of the present study was to evaluate
the prognostic value of baseline RI in the stenotic and
controlateral kidney in predicting the outcome (12-month
follow up) of BP and renal function in hypertensive
patients with unilateral ARAS submitted to successful
revascularization.
Methods
Patients
One hundred and sixty eight patients (mean age 61.2 ±
11.3 years, male 64.9%) were enrolled from 1990 to
2008. Inclusion criteria were:
– Unilateral atherosclerotic renal artery stenosis >60%
defined by a renal to aortic ratio greater than 3.5 at
duplex ultrasound examination [19], confirmed by
angio-magnetic resonance or spiral computed
tomography as recommended [20];– Diagnosis of arterial hypertension according to
current Guidelines [21], with or without chronic
kidney disease;
– Patient’s informed consent;
Exclusion criteria were: fibromuscolar dysplasia; bilat-
eral renal artery stenosis; age > 80 years; KDOQI stage 5
chronic kidney disease (glomerular filtration rate <15 ml/
min or dialysis); history of severe adverse reaction to io-
dinated contrast; technical limitations to revascularization
procedure; severe comorbidities that contraindicated the
intervention according to clinical judgment.
The study was approved by the ethical committee of the
Azienda Ospedaliero-Universitaria Pisana and conformed
the Declaration of Helsinki. In accordance with institu-
tional guidelines, all patients were aware of the investiga-
tional nature of the study and gave written consent to it.
Study design
All the patients underwent abdominal duplex ultrason-
ography (Technos and MyLab25, Esaote, Florence, Italy)
in the month before revascularization after fasting 6–
8 hours. The study was performed by the same operators
(R.M.B and M.S.) using a high resolution multifrequency
(2.5 - 4.5 MHz) Convex probe. Three velocimetric mea-
surements of the interlobar renal arteries adjacent to
medullary pyramids were obtained by a translumbar
and/or anterior approach and RI was calculated accord-
ing to the formula: RI = (systolic peak velocity – end dia-
stolic velocity)/systolic peak velocity, as already reported
in previous studies [22].
Office BP (mean of at least two BP values measured
after 5 minute sitting position by mercury sphygmoman-
ometer) was measured by a trained physician. Office BP
was measured in both arms at the first visit in our center
and then measured in subsequent visits in the arm in
which resulted to be higher. Blood samples were col-
lected in all patients to measure serum creatinine and
other routine parameters, by standard technique. Glom-
erular filtration rate was estimated using the Modifica-
tion of Diet in Renal Disease (MDRD) formula [23].
Angioplasty was performed following Tegtmeyer tech-
nique [24], by using balloon catheters with or without
stent placement following the technique described by
Rees [25]. Digital angiography was performed after the
revascularization to verify the immediate technical suc-
cess, defined as the absence of stenosis or residual sten-
osis < 30%, without complications. Vessel patency was
checked after 24 hours, and after 1-3-6-12 months using
duplex ultrasonography, and confirmed if necessary with
MRI or CT angiography, and subsequent digital angiog-
raphy, defining restenosis as a reduction ≥50% in angio-
graphic diameter. In particular, angiography was repeated
if, according to clinical judgment, a new revascularization
Table 1 Clinical and ultrasonographic parameters of the
study population at baseline
Overall population (n = 168)
Clinical parameters
Age (years) 61.2 ± 11.3
Male sex (%) 64.9
BMI (Kg/m2) 25.4 ± 3.8
Smoking (%) 30.2
Previous cardiovascular events (%) 25.9
Hypercholesterolemia (%) 73.1
Diabetes (%) 16.7
Hypertension duration (years) 8.6 ± 8.5
Systolic blood pressure (mmHg) 161.6 ± 21.2
Diastolic blood pressure (mmHg) 90.0 ± 13.8
Pulse pressure (mm Hg) 71.7 ± 16.9
Number of antihypertensive drugs 2.1 ± 0.9
RAS-blockers therapy 60.0
Antithrombotic therapy (%) 60.5
Cholesterol-lowering therapy (%) 37.5
Serum creatinine (mg/dl) 1.33 ± 0.61
Creatinine clearance (ml/min) 67.2 ± 28.9
Estimated GFR (ml/min/1.73 m2) 61.1 ± 20.5
Albuminuria (mg/24 h) 98.9 ± 278.8
Ultrasonographic parameters Stenotic
kidney
Contralateral
kidney
Resistive index 0.62 ± 0.12* 0.67 ± 0.09
Pulsatility index 1.09 ± 0.36* 1.22 ± 0.31
Renal longitudinal diameter 10.5 ± 1.3 10.7 ± 1.5
Renal to aortic ratio 4.1 ± 0.9* 1.7 ± 0.8
*p < 0.05 vs contralateral kidney.
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sisting in physical examination, office BP measurement,
routine blood exams including serum creatinine, was per-
formed after 1-3-6-12 months. BP and renal outcome
were defined according to the American Heart Associ-
ation guidelines for the reporting of renal artery revascu-
larization in clinical trials [26]. Twelve months after
revascularization patients were classified according to BP
outcome as:
 “Benefit” if: diastolic blood pressure < 90 mm Hg
and/or systolic blood pressure < 140 mm Hg without
pharmacological treatment or on the same or
reduced number of medications (or reduced number
of defined daily doses); reduction in diastolic blood
pressure by at least 15 mm Hg on the same or
reduced number of medications;
 “Failure” if the abovementioned criteria were not
met [26].
Twelve months after revascularization, patients were also
classified in two categories, according to renal outcome:
 “benefit” if there was an increase in eGFR ≥20%
compared to pretreatment values or a value of eGRF
within ±20% of pretreatment values;
 “failure” if there was a deterioration in eGFR ≥20%
after treatment [6,26].
Data analysis
Statistical analysis was performed by means of NCSS
2004 software (NCSS, Kaysville, Utah). Results are ex-
pressed as mean ± SD. Differences between two means
were compared by the Student’s t test for paired or un-
paired observations, as appropriate, while categorical
variables were compared using the chi-square test. Dif-
ferences were considered to be statistically significant
when p was <0.05.
Receiver operating characteristic (ROC) analysis was
performed to calculate the best threshold value of RI as-
sociated with a benefit of revascularization in terms of
BP and renal function outcome, both defined as dichot-
omous variables as explained above. Cut-points selected
were those that yielded the greatest sum of sensitivity
and specificity. Logistic regression analysis was used to
identify independent predictors of clinical outcome, ac-
cording to clinical and ultrasonographic parameters.
Results
Baseline characteristics
Baseline characteristics of the study population are sum-
marized in Table 1. At baseline, RI was significantly
lower in the stenotic kidney as compared to the contralat-
eral, non stenotic, kidney, regardless of the side affected(0.62 ± 0.12 vs 0.67 ± 0.09, p < 0.0001). The percentage of
nephrosclerosis, evaluated as RI >0.70 [27] in the contra-
lateral kidney, was 39%. Reno-aortic ratio was 4.1 ± 0.9 in
the stenotic kidney and 1.7 ± 0.8 in the contralateral kid-
ney (p < 0.0001). According to renal function at baseline,
15 patients were classified in KDOQI (Kidney Disease
Outcomes Quality Initiative) stage 1, 70 in stage 2, 72 in
stage 3, 11 in stage 4.
All the patients underwent angioplasty with (n = 104)
or without stent (n = 64). Before 1995, angioplasty with-
out stenting was the only kind of intervention performed
(n = 25); from 1995 to 2003, angioplasty with stent place-
ment was performed mainly in ostial stenosis (n = 51 out
of 85); from 2003 to 2008, stent placement was per-
formed in all but 5 cases in which was technically not
feasible. The rate of procedure-related major clinical ad-
verse events was 2.4% (3 cases requiring total nephrec-
tomy; 1 arterial thrombosis treated with endoarterectomy),
whereas a residual stenosis was demonstrated soon after
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retroperitoneal bleeding/hematoma and 3 cases of partial
renal ischemia, not requiring medical or surgical interven-
tion and without any clinical sequelae, also occurred. Dur-
ing 12-month follow-up, 24 restenosis in the site of the
intervention occurred, 9 patients developed contralateral
renal artery stenosis, 1 patient died for a cardiovascular
event and 1 patient started dialysis. In total 10 patients
were excluded (4 major procedure-related adverse events,
1 death, 1 dialysis, 4 lost to follow-up), thus the following
analysis were performed on 158 patients.Effect of type of intervention
Clinical and ultrasonographic characteristics, BP and renal
outcome and restenosis rate were analyzed according to
the type of intervention: percutaneous angioplasty with
stent placement (n = 97) versus angioplasty only (n = 61).
At baseline the two groups resulted to be substantially
similar for clinical and ultrasonographic characteristics,
except for a greater diastolic BP in the angioplasty-onlyTable 2 Clinical and ultrasonographic parameters of the study
Benefit (n = 13
Clinical parameters
Age (years) 60.3 ± 10.3†
Male sex (%) 63.5†
BMI (Kg/m2) 25.2 ± 3.6†
Current smoking (%) 32.2
Previous cardiovascular events (%) 28.7
Hypercholesterolemia (%) 74.8
Diabetes (%) 14.4
Hypertension duration (years) 9.1 ± 8.5
Systolic blood pressure (mmHg) 161.7 ± 21.2†
Diastolic blood pressure (mmHg) 91.5 ± 13.9
Pulse pressure (mm Hg) 70.5 ± 16.5†
Number of antihypertensive drugs 2.1 ± 1.0
RAS-blockers therapy 72.2
Antithrombotic therapy (%) 60.4
Cholesterol-lowering therapy (%) 35.2
Serum creatinine (mg/dl) 1.24 ± 0.42†
Creatinine clearance (ml/min) 68.2 ± 25.6†
Estimated GFR (ml/min/1.73 m2) 63.3 ± 18.9†
Albuminuria (mg/24 h) 90.8 ± 282.8
Ultrasonographic parameters Stenotic kidney Cont
Resistive index 0.61 ± 0.11*†
Pulsatility index 1.04 ± 0.31*†
Renal longitudinal diameter 10.7 ± 1.3
Renal to aortic ratio 4.3 ± 1.0*
*p < 0.05 vs contralateral kidney, †p < 0.05 vs failure group.group and a greater use of antithrombotic and lipid-
lowering drugs in the stenting group, the latter probably
due to change in guidelines recommendations over years
(data not shown). No significant difference in terms of re-
stenosis rate (15 vs 9 cases, p = 0.87) and BP outcome fail-
ure (65 vs 34 cases, p = 0.18) was encountered between
patients undergoing angioplasty with or without stenting.
Renal outcome failure tended to be more frequent in sub-
jects receiving only angioplasty (8 vs 12 cases, p = 0.07).Renal function outcome
After 12-month follow-up, a failure in renal function out-
come was demonstrated in 20 patients, while in 138 pa-
tients glomerular filtration rate was unchanged (n = 101)
or improved (n = 36). Patients with worsened renal func-
tion were older, were more frequently males, had a higher
body mass index, higher systolic and pulse pressure values
in comparison to the group who showed benefit from
revascularization (Table 2). At baseline, higher serum
creatinine and proteinuria and a lower glomerularpopulation at baseline according to renal function outcome
8) Failure (n = 20)
67.8 ± 10.1
88.9
27.5 ± 4.1
18.8
37.5
68.4
18.8
6.1 ± 4.9
172.2 ± 21.0
88.2 ± 13.8
84.0 ± 14.9
2.1 ± 1.0
100.0
58.3
31.6
2.06 ± 1.19
50.2 ± 39.2
45.3 ± 24.1
295.3 ± 464.5
ralateral kidney Stenotic kidney Contralateral kidney
0.66 ± 0.09† 0.72 ± 0.11* 0.76 ± 0.08
1.19 ± 0.29† 1.36 ± 0.37* 1.45 ± 0.34
10.8 ± 1.6 10.4 ± 1.3 10.2 ± 1.7
1.9 ± 1.1 3.8 ± 0.8* 1.4 ± 0.9
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group: in particular, 6 out of 11 patients in KDOQI class 4
experienced an eGFR decline greater than 20%. As ultra-
sonographic parameters are concerned, RI in the stenotic
and in the contralateral kidney were both significantly
higher in the failure than in the benefit group (p = 0.001
for both, Table 2), while the RI difference between the two
kidneys was not significantly different (0.03 ± 0.09 vs 0.06 ±
0.10, p = ns).
ROC analysis of main ultrasonographic and clinical
parameters was performed and showed in Table 3. RI in
the contralateral kidney had the largest AUC among the
parameters considered, indicating that it was the most
suitable in predicting benefit in terms of renal function
outcome after revascularization. Among different cut-
points generated, RI in the contralateral kidney >0.73
provided the highest sum of sensitivity and specificity
(Table 3, Figure 1).
In order to verify whether the suggested cut-off was
associated to a unfavourable renal outcome independ-
ently of confounding factors, and particularly of baseline
renal function, a multivariate logistic regression analysis
was performed. In a model comprising also age, gender,
obesity, pulse pressure > 75 mmHg, serum creatinine >
1.80 mg/dl, type of intervention performed, RI in the
contralateral kidney > 0.73 remained an independent
predictor of a failure in renal function outcome (OR
11.3: CI 95% 1.9-66.1) (Figure 2).
At one year follow up, clinical characteristics of pa-
tients classified according renal function outcome were
also analyzed. Patients in the failure group presented a
significantly higher serum creatinine (3.30 ± 2.03 vs 1.14 ±
0.35 mg/dl, p < 0.05) and lower glomerular filtration rate
(27.6 ± 21.9 vs 66.7 ± 26.9 ml/min, p < 0.05) in comparison
to their counterparts. Despite similar systolic and diastolic
BP were observed (148.8 ± 14.3/76.8 ± 11.3 vs 142.7 ±
17.1/81.9 ± 10.9 mmHg, p = ns), pulse pressure (71.9 ±
13.3 vs 60.7 ± 15.2 mmHg, p < 0.05) and the number of
hypertensive drugs (2.5 + 1.2 vs 1.6 + 1.3, p < 0.05) were
significantly greater in the failure group.Table 3 Receiver-operating characteristic analysis of the optim
worsening after revascularization
Parameters AUC 95% confidence interval
RI contralateral kidney 0.77 0.59-0.88
RI stenotic kidney 0.75 0.57-0.86
RI difference 0.58 0.38-0.70
PI contralateral kidney 0.73 0.55-0.84
PI stenotic kidney 0.74 0.54-0.85
Estimated GFR 0.73 0.55-0.85
Serum creatinine 0.74 0.55-0.86
Pulse pressure 0.72 0.60-0.82BP outcome
On the basis of BP outcome, 98 patients were classified
in the benefit category and 60 in the failure category.
Since a higher restenosis rate was encountered in the
failure group (18 vs 6 cases, p < 0.0001), statistical ana-
lysis was performed with the exclusion of the patients
who experienced restenosis (Table 4). Among clinical
baseline characteristics, the benefit group had higher
diastolic and lower pulse pressure values, shorter hyper-
tension duration, and milder proteinuria. On the con-
trary, patients with positive or negative BP outcome
were not different for any of the considered ultrasono-
graphic parameters (Table 4). In particular RI between
the benefit and the failure group was similar, both in the
stenotic (0.62 ± 0.13 vs 0.65 ± 0.12, p = ns) and in the
controlateral (0.67 ± 0.10 vs 0.68 ± 0.11, p = ns) kidney,
as well as RI difference between stenotic and contralat-
eral kidney (0.06 ± 0.11 vs 0.04 ± 0.10, p = ns). Results
were superimposable when patients who experienced re-
stenosis were included (data not shown).
Discussion
The present study demonstrated that RI in the contralat-
eral kidney is an independent predictor of renal function
outcome after successful revascularization in hyperten-
sive patients with unilateral atherosclerotic renal artery
stenosis, whereas it is not able to predict blood pressure
outcome.
Past and ongoing trials [2-6] have been trying to ran-
domly compare revascularization procedures and med-
ical therapy in populations of hypertensive patients with
ARAS in order to establish whether interventional ap-
proach could be beneficial in terms of BP and renal func-
tion outcome. Recently, ASTRAL, STAR and CORAL
trials [5-7] showed no difference in outcome in patients
randomly assigned to either receive renal artery revascu-
larization or medical treatment. These discouraging re-
sults strengthened the necessity for reliable selection
criteria, not only to achieve successful results in the po-
tentially curable patients but also to avoid adverse eventsal cut-points of parameters in predicting renal function
Cutpoint Sensitivity (%) Specificity (%)
0.73 80 72
0.67 81 69
0.09 79 34
1.32 69 75
1.18 80 68
48 ml/min 1.73 m2 79 67
1.8 mg/dl 59 91
75 mmHg 61 73
Figure 1 Receiver-operating characteristic curves of resistive index in the contralateral (A) and in the stenotic (B) kidney for renal
function worsening.
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benefit from the interventional approach [28,29].
Renal RI has been demonstrated to be useful as a
negative prognostic index for renal function outcome by
Radermacher and colleagues [9,10], showing that an RI
>0.80 identifies patients who would not benefit from re-
vascularization in terms of renal function. The ability to
identify such patients is particularly important, because
preservation of renal function is one of main rationales
for performing angioplasty in patients with renal artery
stenosis. However the cited paper left several questions
open. First, this cut-off identifies a very small subset of
aged patients with cardiovascular comorbidities, ad-
vanced atherosclerosis, chronic kidney failure, that might
be probably excluded from interventional procedures: in
our cohort, which is younger and with a lower preva-
lence of severe chronic kidney disease and previous car-
diovascular events, only 19 out of 168 patients showed
RI > 0.80 either in the stenotic or in the contralateral
kidney. Our results suggest that in settings characterized
by lower cardiovascular and renal morbidities, the cut-
off of 0.80 is hardly applicable, thus explaining conflict-
ing results found by other authors [8,13-18]. Second, it
is not clear whether the 0.80 cut-off should refer toFigure 2 Odds ratio (95% confidence interval) for renal function wors
analysis. The model comprised also age as a continuous variable.stenotic or controlateral kidney, given the profoundly
different hemodynamic conditions to which the two kid-
neys are exposed. Contralateral kidney evaluation might
be more correct from a pathophysiological point of view,
since it is the one openly exposed to BP overload. How-
ever, the approach suggested in this paper is limited to
unilateral atherosclerotic lesions.
The present study showed a 13% of patients who had
worsened renal function, defined as a GFR decline of at
least 20%, one year after revascularization. RI in the
stenotic as well as in the contralateral kidney were both
significantly higher in patients with no benefit in terms
of renal function in comparison to their counterparts;
this is in line with the previous report by Radermacher
and coauthors, suggesting an high RI as a significant
negative prognostic factor [9]. We considered different
ultrasonographic parameters to identify the best pre-
dictor, and compared them to main clinical determinants
of renal function outcome: baseline renal function and
blood pressure. We found that RI in the contralateral
kidney >0.73 provided the largest area under the curve,
and acceptable values for sensitivity (80%) and specificity
(72%). Furthermore, the logistic regression analysis
indicated baseline RI in the contralateral kidney as anening after revascularization in a multivariate logistic regression
Table 4 Clinical and ultrasonographic parameters of the study population at baseline according to blood pressure outcome
Benefit (n = 90) Failure (n = 42)
Clinical parameters
Age (years) 62.0 ± 10.1 61.3 ± 12.1
Male sex (%) 64.4 61.9
BMI (Kg/m2) 25.7 ± 3.6 25.0 ± 3.5
Current smoking (%) 28.2 33.3
Previous cardiovascular events (%) 25.3 31.4
Hypercholesterolemia (%) 77.5 64.1
Diabetes (%) 18.3 17.1
Hypertension duration (years) 7.3 ± 7.1† 12.1 ± 11.1
Systolic blood pressure (mmHg) 162.6 ± 22.8 161.9 ± 17.8
Diastolic blood pressure (mmHg) 92.5 ± 13.7 † 85.9 ± 14.2
Pulse pressure (mm Hg) 70.1 ± 16.3† 76.3 ± 17.5
Number of antihypertensive drugs 2.1 ± 0.9 2.2 ± 1.0
RAS-blockers therapy 58.8 62.2
Antithrombotic therapy (%) 61.9 58.9
Cholesterol-lowering therapy (%) 36.7 31.0
Serum creatinine (mg/dl) 1.37 ± 0.66 1.36 ± 0.69
Creatinine clearance (ml/min) 64.3 ± 30.4 69.6 ± 27.6
Estimated GFR (ml/min/1.73 m2) 59.9 ± 20.8 61.4 ± 22.4
Albuminuria (mg/24 h) 22 ± 39† 359 ± 520
Ultrasonographic parameters Stenotic kidney Contralateral kidney Stenotic kidney Contralateral kidney
Resistive index 0.62 ± 0.13* 0.67 ± 0.10 0.65 ± 0.12* 0.68 ± 0.11
Pulsatility index 1.07 ± 0.35* 1.21 ± 0.28 1.17 ± 0.39* 1.27 ± 0.42
Renal longitudinal diameter 10.5 ± 1.2 10.8 ± 1.7 10.4 ± 1.6 10.5 ± 1.6
Renal to aortic ratio 4.1 ± 0.9* 1.8 ± 1.0 3.9 ± 1.1* 1.7 ± 0.9
*p < 0.05 vs contralateral kidney, †p < 0.05 vs failure group.
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after adjustment for clinical characteristics that were as-
sociated with a worse outcome, suggesting that it could
contribute to select those patients who will not benefit
from renal revascularization. However, it should be
taken into account that sensitivity and specificity were
probably not sufficiently high to put this index right into
clinical practice; moreover, the superiority in comparison
to routine evaluation, such as serum creatinine at base-
line, resulted to be limited.
It is interesting to note that in a relevant percentage of
patients the contralateral kidney was characterized by
nephrosclerosis, identified by a RI > 0.70 [27]. Indeed,
the presence of stenosis leads to an activation of sys-
temic mechanisms which can induce the progression of
the atherosclerotic process and renal damage [30]. The-
oretically, contralateral kidney is the one openly exposed
to BP overload, without the paradoxical protection of
the stenosis. Therefore, RI in the contralateral kidney
can be considered the direct expression of the actual
renal damage caused by high BP over time and by theconsequent activation of local detrimental processes
such as oxidative stress and inflammation, in parallel to
what occurs in essential hypertension [31,32]. Worth of
note, the greater sensitivity and specificity in predicting
the renal function outcome has been reached when RI in
the contralateral kidney rather than in the stenotic kid-
ney has been analyzed.
The present study confirmed previous results [33] that
showed a lower RI in the stenotic kidney as compared to
the RI in the contralateral kidney, likely due to the post
stenotic vasodilation in the affected kidney apparently
compensating the presence of the stenosis. Accordingly,
we tested RI difference between contralateral and sten-
otic kidney as a possible predictor of revascularization
outcome, since it might represent an index of renal com-
pensatory vasodilation, in the hypothesis that a higher RI
difference could correspond to a less advanced renal
damage in the stenotic kidney. Although RI difference
tended to be higher in both the groups with BP and
renal function benefit, these results did not reach statis-
tical significance. Preliminary data from our group
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stimulus might be an effective test to predict BP out-
come [34].
In terms of BP outcome, the results of the present
study, showing a 64% of cured/improved and a 32% of
patients with no benefit at one year follow up after re-
vascularization, are consistent with those of previous
studies [2-4]. Our study failed to demonstrate a predict-
ive role of any of the considered ultrasonographic
parameters for BP outcome. On the other hand, hyper-
tension duration, rather than age, appear to influence BP
outcome after revascularization, conceivably by means of
development of structural vascular changes, that are
hardly reversible [35]. This hypothesis is supported by
the fact that pulse pressure, a surrogate marker of large
artery stiffness [36], and albuminuria, considered a
marker of widespread vascular damage [37] in the hyper-
tensive population, are among the parameters associated
with worse BP outcome. Recently Leeser and collegues
demonstrated that evaluation of translesional pressure
gradients allows a satisfying BP improvement prediction
[38]. Thus it is conceivable that also local factors such as
the entity of the stenosis, play a major role in BP response
to revascularization. Furthermore, the use of office BP in-
stead of 24-hour BP monitoring, one of the limitations of
the present study, could have contributed to lack of sig-
nificance of the results regarding BP outcome.Perspectives
These data indicate that duplex ultrasound evaluation of
RI in the contralateral kidney is an independent pre-
dictor of renal function outcome after successful revas-
cularization in hypertensive patients with unilateral
atherosclerotic renal artery stenosis, whereas it is not
able to predict blood pressure outcome.
The results of the present study suggest that RI evalu-
ation could contribute, at least in part, to better identify
patients that could benefit from revascularization. At the
moment, renal artery revascularization has not been
demonstrated to be superior to medical therapy in
hypertensive patients with RAS, possibly due to inad-
equate patient selection. Thus it is desirable to design fur-
ther studies with the aim of identify non-invasive, highly
predictive diagnostic tests in order to limit renal revascu-
larization to patients who will really benefit from it.
Abbreviations
ARAS: Atherosclerotic renal artery stenosis; AUC: Area under the curve;
BP: Blood pressure; KDOQI: Kidney Disease Outcomes Quality Initiative;
RI: Renal resistive index; MDRD: Modification of Diet in Renal Disease;
eGFR: Estimated glomerular filtration rate; ROC: Receiver operating
characteristic.
Competing interests
The authors declare that they have no competing interests.Authors’ contributions
RMB and ED and performed statistical analysis and drafted the manuscript;
ST, SP, LG, conceived the study and participated in its design; MS performed
ultrasound exams; MS, LV, CR, IDP, ED collected data and were involved in
the clinical follow-up; DV, SP and LOL participated in design and coordination
of the study and critically revised the manuscript. All authors read and approved
the final manuscript.
Author details
1Department of Clinical and Experimental Medicine, University of Pisa, Pisa,
Italy. 2Institute of Clinical Physiology – CNR, Via Moruzzi 1, 56124 Pisa, Italy.
3University Heart Center, University Hospital Zurich, Zurich, Switzerland.
4Department of Interventional Radiology, University Hospital of Pisa, Pisa,
Italy. 5Department of Internal Medicine, Division of Nephrology and
Hypertension, Mayo Clinic College of Medicine, Rochester, MN, USA.
Received: 15 January 2014 Accepted: 13 February 2014
Published: 20 February 2014
References
1. Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA,
Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V,
Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B:
ACC/AHA 2005 Practice Guidelines for the management of patients with
peripheral arterial disease (lower extremity, renal, mesenteric, and
abdominal aortic): a collaborative report from the American Association
for Vascular Surgery/Society for Vascular Surgery, Society for
Cardiovascular Angiography and Interventions, Society for Vascular
Medicine and Biology, Society of Interventional Radiology, and the ACC/
AHA Task Force on Practice Guidelines (Writing Committee to Develop
Guidelines for the Management of Patients With Peripheral Arterial
Disease): endorsed by the American Association of Cardiovascular and
Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute;
Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and
Vascular Disease Foundation. Circulation 2006, 113(11):e463–e654.
2. Plouin PF, Chatellier G, Darne B, Raynaud A: Blood pressure outcome of
angioplasty in atherosclerotic renal artery stenosis: a randomized trial.
Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group.
Hypertension 1998, 31(3):823–829.
3. van de Ven PJ, Kaatee R, Beutler JJ, Beek FJ, Woittiez AJ, Buskens E,
Koomans HA, Mali WP: Arterial stenting and balloon angioplasty in ostial
atherosclerotic renovascular disease: a randomised trial. Lancet 1999,
353(9149):282–286.
4. van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT,
Dees A, Woittiez AJ, Bartelink AK, Man in’t Veld AJ, Schalekamp MA: The
effect of balloon angioplasty on hypertension in atherosclerotic renal-
artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative
Study Group. N Engl J Med 2000, 342(14):1007–1014.
5. Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N,
Eadington D, Hamilton G, Lipkin G, Nicholson A, Scoble J: Revascularization versus
medical therapy for renal-artery stenosis. N Engl J Med 2009, 361(20):1953–1962.
6. Bax L, Woittiez AJ, Kouwenberg HJ, Mali WP, Buskens E, Beek FJ, Braam B,
Huysmans FT, Schultze Kool LJ, Rutten MJ, Doorenbos CJ, Aarts JC, Rabelink TJ,
Plouin PF, Raynaud A, Van Montfrans GA, Reekers JA, Van Den Meiracker AH,
Pattynama PM, Van De Ven PJ, Vroegindeweij D, Kroon AA, De Haan MW,
Postma CT, Beutler JJ: Stent placement in patients with atherosclerotic renal
artery stenosis and impaired renal function: a randomized trial. Ann Intern
Med 2009, 150(12):840–848. W150-841.
7. Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen
DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR,
Shapiro JI, Rundback JH, Massaro JM, D'agostino RB Sr, Dworkin LD:
Stenting and medical therapy for atherosclerotic renal-artery stenosis. N
Engl J Med 2014, 370(1):13–22.
8. Frauchiger B, Zierler R, Bergelin RO, Isaacson JA, Strandness DE Jr:
Prognostic significance of intrarenal resistance indices in patients with
renal artery interventions: a preliminary duplex sonographic study.
Cardiovasc Surg 1996, 4(3):324–330.
9. Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, Galanski
M, Koch KM, Haller H: Use of Doppler ultrasonography to predict the
outcome of therapy for renal-artery stenosis. N Engl J Med 2001,
344(6):410–417.
Bruno et al. Cardiovascular Ultrasound 2014, 12:9 Page 9 of 9
http://www.cardiovascularultrasound.com/content/12/1/910. Radermacher J, Ellis S, Haller H: Renal resistance index and progression of
renal disease. Hypertension 2002, 39(2 Pt 2):699–703.
11. Viazzi F, Leoncini G, Derchi LE, Pontremoli R: Ultrasound Doppler renal
resistive index: a useful tool for the management of the hypertensive
patient. J Hypertens 2014, 32(1):149–153.
12. Krumme B, Hollenbeck M: Doppler sonography in renal artery stenosis–
does the Resistive Index predict the success of intervention? Nephrol Dial
Transplant 2007, 22(3):692–696.
13. Zeller T, Muller C, Frank U, Burgelin K, Horn B, Schwarzwalder U, Cook-Bruns
N, Neumann FJ: Stent angioplasty of severe atherosclerotic ostial renal
artery stenosis in patients with diabetes mellitus and nephrosclerosis.
Catheter Cardiovasc Interv 2003, 58(4):510–515.
14. Cianci R, Martina P, Cianci M, Lavini R, Stivali G, Di Donato D, Polidori L,
Lai S, Renzulli R, Gigante A, Barbano B: Ischemic nephropathy: proteinuria
and renal resistance index could suggest if revascularization is
recommended. Ren Fail 2010, 32(10):1167–1171.
15. Garcia-Criado A, Gilabert R, Nicolau C, Real MI, Muntana X, Blasco J, Ganau S,
Bru C: Value of Doppler sonography for predicting clinical outcome after
renal artery revascularization in atherosclerotic renal artery stenosis.
J Ultrasound Med 2005, 24(12):1641–1647.
16. Santos SN, Leite LR, Tse TS, Beck R, Lee RA, Shepherd RF: [Renal resistance
index predicting outcome of renal revascularization for renovascular
hypertension]. Arq Bras Cardiol 2010, 94(4):452–456.
17. Soulez G, Therasse E, Qanadli SD, Froment D, Leveille M, Nicolet V, Turpin S,
Giroux MF, Guertin MC, Oliva VL: Prediction of clinical response after renal
angioplasty: respective value of renal Doppler sonography and
scintigraphy. AJR Am J Roentgenol 2003, 181(4):1029–1035.
18. Voiculescu A, Schmitz M, Plum J, Hollenbeck M, Vupora S, Jung G, Modder
U, Pfeiffer T, Sandmann W, Willers R, Grabensee B: Duplex ultrasound and
renin ratio predict treatment failure after revascularization for renal
artery stenosis. Am J Hypertens 2006, 19(7):756–763.
19. Hoffmann U, Edwards JM, Carter S, Goldman ML, Harley JD, Zaccardi MJ,
Strandness DE Jr: Role of duplex scanning for the detection of
atherosclerotic renal artery disease. Kidney Int 1991, 39(6):1232–1239.
20. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka
LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC,
Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams
CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK,
Nishimura R, Ornato JP, Page RL, Riegel B: ACC/AHA 2005 guidelines for
the management of patients with peripheral arterial disease (lower
extremity, renal, mesenteric, and abdominal aortic): executive summary
a collaborative report from the American Association for Vascular
Surgery/Society for Vascular Surgery, Society for Cardiovascular
Angiography and Interventions, Society for Vascular Medicine and
Biology, Society of Interventional Radiology, and the ACC/AHA Task
Force on Practice Guidelines (Writing Committee to Develop Guidelines
for the Management of Patients With Peripheral Arterial Disease)
endorsed by the American Association of Cardiovascular and Pulmonary
Rehabilitation; National Heart, Lung, and Blood Institute; Society for
Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular
Disease Foundation. J Am Coll Cardiol 2006, 47(6):1239–1312.
21. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G,
Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L,
Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J,
De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C,
Hellemans I, Kristensen SD, Mcgregor K, Sechtem U, Silber S, Tendera M,
Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni
E, Lindholm LH, Viigimaa M, Adamopoulos S, Bertomeu V, Clement D,
Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'brien E,
Ponikowski P, Redon J, Ruschitzka F, Tamargo J, Van Zwieten P, Waeber B,
Williams B: 2007 Guidelines for the Management of Arterial
Hypertension: The Task Force for the Management of Arterial
Hypertension of the European Society of Hypertension (ESH) and of the
European Society of Cardiology (ESC). J Hypertens 2007, 25(6):1105–1187.
22. Bruno RM, Daghini E, Landini L, Versari D, Salvati A, Santini E, Di Paco I,
Magagna A, Taddei S, Ghiadoni L, Solini A: Dynamic evaluation of renal
resistive index in normoalbuminuric patients with newly diagnosed
hypertension or type 2 diabetes. Diabetologia 2011, 54(9):2430–2439.23. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate
method to estimate glomerular filtration rate from serum creatinine: a
new prediction equation. Modification of Diet in Renal Disease Study
Group. Ann Intern Med 1999, 130(6):461–470.
24. Tegtmeyer CJ: Percutaneous renal revascularization. Mayo Clin Proc 1995,
70(11):1127–1129.
25. Rees CR: Stents for atherosclerotic renovascular disease. J Vasc Interv
Radiol 1999, 10(6):689–705.
26. Rundback JH, Sacks D, Kent KC, Cooper C, Jones D, Murphy T, Rosenfield K,
White C, Bettmann M, Cortell S, Puschett J, Clair D, Cole P: Guidelines for
the reporting of renal artery revascularization in clinical trials. American
Heart Association. Circulation 2002, 106(12):1572–1585.
27. Platt JF, Ellis JH, Rubin JM: Examination of native kidneys with duplex
Doppler ultrasound. Semin Ultrasound CT MR 1991, 12(4):308–318.
28. Rocha-Singh K, Jaff MR, Lynne Kelley E: Renal artery stenting with
noninvasive duplex ultrasound follow-up: 3-year results from the
RENAISSANCE renal stent trial. Catheter Cardiovasc Interv 2008,
72(6):853–862.
29. Textor SC, McKusick MM, Misra S, Glockner J: Timing and selection for
renal revascularization in an era of negative trials: what to do?
Prog Cardiovasc Dis 2009, 52(3):220–228.
30. Lerman LO, Textor SC, Grande JP: Mechanisms of tissue injury in renal
artery stenosis: ischemia and beyond. Prog Cardiovasc Dis 2009,
52(3):196–203.
31. Derchi LE, Leoncini G, Parodi D, Viazzi F, Martinoli C, Ratto E, Vettoretti S,
Vaccaro V, Falqui V, Tomolillo C, Deferrari G, Pontremoli R: Mild renal
dysfunction and renal vascular resistance in primary hypertension.
Am J Hypertens 2005, 18(7):966–971.
32. Pontremoli R, Viazzi F, Martinoli C, Ravera M, Nicolella C, Berruti V, Leoncini
G, Ruello N, Zagami P, Bezante GP, Derchi LE, Deferrari G: Increased renal
resistive index in patients with essential hypertension: a marker of target
organ damage. Nephrol Dial Transplant 1999, 14(2):360–365.
33. Krumme B, Blum U, Schwertfeger E, Flugel P, Hollstin F, Schollmeyer P,
Rump LC: Diagnosis of renovascular disease by intra- and extrarenal
Doppler scanning. Kidney Int 1996, 50(4):1288–1292.
34. Daghini E, Bruno RM, Versari D, Ghiadoni L, Di Paco I, Sudano I, Sgrò M,
Pinto S, Taddei S, Salvetti A: Dynamic resistive index (DRIN) for prediction
of blood pressure outcome after successful rivascularization in
hypertensive patients with unilateral atherosclerotic renal artery
stenosis. J Hypertens 2009, 27:S373.
35. Safar ME, Rizzoni D, Blacher J, Muiesan ML, Agabiti-Rosei E: Macro and
microvasculature in hypertension: therapeutic aspects. J Hum Hypertens
2008, 22(9):590–595.
36. Franklin SS: Pulse pressure as a risk factor. Clin Exp Hypertens 2004,
26(7–8):645–652.
37. Ruilope LM: The kidney as a sensor of cardiovascular risk in essential
hypertension. J Am Soc Nephrol 2002, 13(Suppl 3):S165–S168.
38. Leesar MA, Varma J, Shapira A, Fahsah I, Raza ST, Elghoul Z, Leonard AC,
Meganathan K, Ikram S: Prediction of hypertension improvement after
stenting of renal artery stenosis: comparative accuracy of translesional
pressure gradients, intravascular ultrasound, and angiography.
J Am Coll Cardiol 2009, 53(25):2363–2371.
doi:10.1186/1476-7120-12-9
Cite this article as: Bruno et al.: Predictive role of renal resistive index
for clinical outcome after revascularization in hypertensive patients with
atherosclerotic renal artery stenosis: a monocentric observational study.
Cardiovascular Ultrasound 2014 12:9.
